Navigation Links
Sigma-Aldrich (Nasdaq: SIAL) Annual Sales Surpass $2 Billion Mark.
Date:2/12/2008

Interest, net 4.5 5.9 22.0 24.0

Income before income taxes 113.4 93.5 437.6 378.7

Provision for income taxes 28.5 21.9 126.5 101.9

Net income $84.9 $71.6 $311.1 $276.8

Net income per share - Basic $0.66 $0.54 $2.38 $2.08

Net income per share - Diluted $0.64 $0.53 $2.34 $2.05

Weighted average number of shares

outstanding - Basic 129.6 132.0 130.6 132.9

Weighted average number of shares

outstanding - Diluted 132.4 134.2 133.1 134.9

SIGMA-ALDRICH CORPORATION

Consolidated Balance Sheets

(in millions)

(Unaudited)

December 31, December 31,

2007 2006

Assets

Current assets:

Cash and cash equivalents $237.6 $173.8

Accounts receivable, net 276.3 248.0

Inventories 653.6 596.0

Deferred taxes 57.7 49.6

Other current assets 57.3 45.5

Total current assets 1,282.5 1,112.9

Property, plant and equipment, net 681.5 645.1

Goodwill, net 420.3 361.3

Intangibles, net 136.9 126.0

Other assets 107.9 89.0

Total assets $2,629.1 $2,334.3

Liabilitie
'/>"/>

SOURCE Sigma-Aldrich Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20

Related biology technology :

1. Sigma-Aldrich (Nasdaq: SIAL) Declares Quarterly Dividend
2. Sigma-Aldrich and Lab Manager Magazine Present Webinar On Laboratory Environmental, Health and Safety Compliance Strategies
3. Sigma-Aldrich Expansion in Republic of China to Support SAFC Growth
4. Sigma-Aldrich and Ingenuity Systems Announce Partnership to Create E-Commerce Search Solution Based on Biological Knowledge
5. Sigma-Aldrich to Present at the UBS 2007 Global Life Sciences Conference on September 25, 2007
6. Sigma-Aldrich Names Patrick Sullivan New VP of Research and Development for Research Biotech
7. Sigma-Aldrich and the Universite de Montreal Establish Collaboration for RNA Interference Studies
8. Sigma-Aldrich Corporations 3rd Quarter 2007 Earnings Conference Call
9. Sigma-Aldrich Introduces N-TER Nanoparticle siRNA Transfection System for Delivery of siRNA Into Difficult-to-Transfect Cell Types
10. Sigma-Aldrich (Nasdaq: SIAL) Q3 2007 Sales Increase 14.0%, Yielding Diluted EPS of $.54.
11. Sigma-Aldrich and Oxford BioMedica Win Key Ruling in Open Biosystems Patent Infringement Dispute
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2015)... , March 30, 2015 /CNW/ - A new ... on the salaries and demographic profiles of new graduates ... the Door – Building Careers for New Grads in ... Research-Based Pharmaceutical Companies (Rx&D) and features data ... Career Focus wage subsidy program from 2013 to 2015. ...
(Date:3/30/2015)... PARK, N.J. , March 30, 2015 /PRNewswire/ ... (PAMORA) under development by Shionogi & Co., Ltd., ... phase III study (COMPOSE I) for the treatment ... chronic non-cancer pain receiving opioid therapy. Study results ... daily) statistically significantly improved the frequency of spontaneous ...
(Date:3/29/2015)... , March 29, 2015 ... of important study data showing the presence ... 1,599 gynecologic cancer samples. Using Caris Molecular ... service, researchers identified expression of programmed cell ... independent of histology while its ligand (PD-L1) ...
(Date:3/27/2015)... , March 27, 2015  Neogen Corporation (NASDAQ: ... has adopted a prearranged trading plan in accordance with ... , Chairman and CEO of Neogen Corporation, is a ... Neogen Corporation common stock. Herbert does not ... was appropriate. The filing is only for a portion ...
Breaking Biology Technology:New Report on Graduates in Canadian Biotech Industry Sheds Light on Hiring Practices 2New Report on Graduates in Canadian Biotech Industry Sheds Light on Hiring Practices 3New Report on Graduates in Canadian Biotech Industry Sheds Light on Hiring Practices 4Shionogi & Co., Ltd. Announces That Naldemedine Meets Primary Endpoint In A Phase 3 Study For The Treatment Of Opioid-Induced Constipation 2Shionogi & Co., Ltd. Announces That Naldemedine Meets Primary Endpoint In A Phase 3 Study For The Treatment Of Opioid-Induced Constipation 3Caris Life Sciences' Multiplatform Tumor Profiling Technology Identifies Expression of PD-1 and PD-L1 in Gynecologic Malignancies 2Caris Life Sciences' Multiplatform Tumor Profiling Technology Identifies Expression of PD-1 and PD-L1 in Gynecologic Malignancies 3Caris Life Sciences' Multiplatform Tumor Profiling Technology Identifies Expression of PD-1 and PD-L1 in Gynecologic Malignancies 4Neogen CEO adopts 10b5-1 Trading Plan 2
... available in German . Probiotic ... However, the production of this "functional food" has its ... to survive conventional production processes. Researchers from Technische Universitaet ... allows the use of thus far unutilized probiotics. The ...
... the space shuttle Atlantis will streak skyward from the Kennedy ... the STS-135 flight marks the end of the space shuttle,s ... of research into infectious diseases, thanks to space bound experiments ... with their colleagues at Arizona State University,s Biodesign Institute. ...
... oldest known life-forms, but they are not well understood. ... microorganisms were designated as a domain of life distinct ... Robert Gunsalus, a UCLA professor of microbiology, immunology ... because of their ability to thrive in harsh ...
Cached Biology Technology:TUM researchers develop environmentally friendly process to improve storage stability of probiotics 2TUM researchers develop environmentally friendly process to improve storage stability of probiotics 3Final countdown: Atlantis to carry next-generation vaccine candidate on last space voyage 2Final countdown: Atlantis to carry next-generation vaccine candidate on last space voyage 3Final countdown: Atlantis to carry next-generation vaccine candidate on last space voyage 4Old life capable of revealing new tricks after all 2Old life capable of revealing new tricks after all 3
(Date:3/17/2015)... Minn. , March 17, 2015 ... technology company specializing in clinical study management systems, ... be in attendance at ARENA,s Outsourcing in Clinical ... NC.  This event provides an excellent forum for ... easy-to-use, flexible and affordable software-as-a-service (SaaS) eClinical technology ...
(Date:3/17/2015)... , March 17, 2015  MecklerMedia Corporation (OTCQX: ... exhibition for service robots ever held in ... place on May 11-13, 2015 at the Javits ... for the event include: Acorn Product Development; Axis ... Infranor; Kinova Robotics; Littler; NewBotic Corporation; Neya Systems ...
(Date:3/12/2015)... , March 12, 2015 IriTech, a ... a member of the Texas Instruments Design Network, announced ... has demonstrated its IriShield USB MK2120U device during ... facility for pension distribution. The iris ... to be marketed in India ...
Breaking Biology News(10 mins):Connect With MedNet Solutions At Outsourcing In Clinical Trials Southeast 2MecklerMedia's RoboUniverse New York Announces Sponsors and Exhibitors, May 11-13, 2015 2Indian States See IriTech's Scanner Bolstering Efficiency of Authentication for Aadhaar 2Indian States See IriTech's Scanner Bolstering Efficiency of Authentication for Aadhaar 3
... researchers is working to characterize the genes involved in wood ... quality and quantity of wood as a feedstock for biofuels ... important complement to the work of other biofuels researchers who ... for biofuels," said Eric Beers, professor of horticulture and the ...
... 2011 ID World 2011, the International Congress ... presented its ID People Trail Blazer Award to Peter Went, ... award was announced at the 2011 ID World International Congress ... de la Giroday. The Trail Blazer Award honors pioneering researchers ...
... German . For the first time, ... Research in Rostock (MPIDR) has calculated a profile that illustrates ... This profile applies to U.S. citizens, as data for this ... the analysis is universally valid, and can be applied to ...
Cached Biology News:Genomics of wood for biofuels production investigated 2Peter Went Wins ID People's Trail Blazer Awards 2Individual CO2 emissions decline in old age 2Individual CO2 emissions decline in old age 3Individual CO2 emissions decline in old age 4
... interferons are cytopathic effect inhibition assays, also known ... include; tissue culture supernatents; serum from PK studies ... unit is defined as the quantity of interferon ... of viral infection by 50%. All ...
... effect inhibition assays, also known as CPE and ... supernatents; serum from PK studies and delivery formulations. ... as the quantity of interferon required per milliliter ... by 50%. All standards used in ...
...
Request Info...
Biology Products: